PT-141 (Bremelanotide) 10mg

Description

PT-141 (Bremelanotide) 10 mg is a synthetic heptapeptide α-MSH analogue under investigation in melanocortin-receptor and reproductive-axis research.

Research Profile

• α-MSH analogue heptapeptide
• Studied in melanocortin-receptor and reproductive-axis research
• Long history of clinical and academic research
• QC verified by HPLC and mass spectrometry

Specifications

• Compound: PT-141 (Bremelanotide)
• Dosage: 10 mg per vial
• Purity: ≥ 98% (HPLC)
• Form: Lyophilized powder
• Storage: 2–8 °C (lyophilized); –20 °C (reconstituted)

For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.